Skip to main content

Table 6 Impact of generic substitution on research and development of new pharmaceutical productsa.

From: The impact of generic substitution on the activities of pharmaceutical companies - a survey from the companies' perspective one year and five years after the introduction of generic substitution in finland

 

Survey 2004

Survey 2008

 

Original product companies

n (%)a

Generic product companies

n (%)

Total

n (%)b

P-value

Original product companies

n (%)

Generic product companies

n (%)

Total

n (%)

P-value

Has generic substitution influenced the research and development of new pharmaceutical products in Finland in your company?*

   

0.161

   

0.154

No

8 (57)

2 (67)

10 (59)

 

8 (67)

3 (75)

11 (69)

 

Research and development has decreased

5 (36)

-

5 (29)

 

4 (33)

-

4 (25)

 

Research and development has increased

-

1 (33)

1 (6)

 

-

-

-

 

Some other impactc

2 (14)

-

2 (12)

 

-

1 (25)

1 (6)

 

Total

14 (107)

3 (100)

17 (106)

 

12 (100)

4 (100)

16 (100)

 
  1. * P-value between the 2004 and 2008 surveys in the original product companies (p = 0.594) and in the generic product companies (p = 1.000)
  2. a The table contains only the responses of companies that conducted research and development of new pharmaceutical products.
  3. bOne company chose two impacts (research and development has decreased and some other impact).
  4. cFor example, the research of pharmaceutical products within generic substitution does not interest no longer, research and development will be directed to new pharmacotherapy areas.